NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹6,247 Cr | ₹4,466 Cr | ₹3,292 Cr | ₹2,667 Cr | ₹2,568 Cr |
What is the latest Profit & Loss Account Balance ratio of NATCO PHARMA ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹6,247 Cr |
| Mar2024 | ₹4,466 Cr |
| Mar2023 | ₹3,292 Cr |
| Mar2022 | ₹2,667 Cr |
| Mar2021 | ₹2,568 Cr |
How is Profit & Loss Account Balance of NATCO PHARMA Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,247 Cr | 39.88 | |
| Mar2024 | ₹4,466 Cr | 35.64 | |
| Mar2023 | ₹3,292 Cr | 23.46 | |
| Mar2022 | ₹2,667 Cr | 3.83 | |
| Mar2021 | ₹2,568 Cr | - | |
Compare Profit & Loss Account Balance of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,946.2 Cr | -1.7% | 2.6% | -31.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -1.7% |
2.6% |
-31.4% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses